Inventor
Jesper Gromada
Inventor
Scarsdale, NY, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides28%
C12NMicroorganisms or enzymes4%
A01KAnimal husbandry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,045,522Glucagon-like peptide 1 receptor agonists and uses thereof202110,995,146Methods of treating severe insulin resistance by interfering with glucagon receptor signaling202110,961,583Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation202110,947,310Fusion protein comprising apelin and an anti-APLNR antibody202110,787,647HSD17B13 variants and uses thereof202010,626,173Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR202010,618,968Antigen-binding proteins that activate the leptin receptor202010,582,702Non-human animals having an engineered ANGPTL8 gene202010,550,192Antigen-binding proteins that antagonize leptin receptor202010,548,302Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy202010,526,403Anti-activin A antibodies and uses thereof202010,519,240Anti-FGFR1c antibody-FGF21 fusion proteins201910,442,856Methods of treating obesity with anti-ANGPTL8 antibodies201910,259,870Anti-ANGPTL8 antibodies and uses thereof201910,253,102Antigen-binding proteins that activate the leptin receptor201910,189,901Methods for improving cardiac function by administering an antibody that activates APLNR201910,155,811APLNR modulators and uses thereof201810,023,644Antigen-binding proteins that activate the leptin receptor20189,718,881'Anti-Activin A antibodies and uses thereof'20179,657,099'Anti-glucagon antibodies'20179,644,018'Antibody modulators of APLNR'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2021Patents assigned to REGENERON PHARMA (21)· patent assignee history
2017–2021Based in Scarsdale, NY, US· patent location history
2020–2021Based in Tarrytown, NY, US· patent location history
2020Based in Concord, MA, US· patent location history
2021Patents assigned to REGENEREN PHARMACEUTICALS INC (1)· patent assignee history
2021Patents assigned to REGENERON PHRAMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 21 | 2017–2021 |
| REGENEREN PHARMACEUTICALS INC | 1 | 2021 |
| REGENERON PHRAMACEUTICALS INC | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Scarsdale, New York, US | 18 | 2017–2021 |
| Tarrytown, New York, US | 2 | 2020–2021 |
| Concord, Massachusetts, US | 1 | 2020 |